Previous Close | 21.40 |
Open | 21.37 |
Bid | 21.47 x 100 |
Ask | 21.48 x 100 |
Day's Range | 21.37 - 21.48 |
52 Week Range | 2.31 - 21.55 |
Volume | |
Avg. Volume | 2,160,341 |
Market Cap | 1.822B |
Beta (5Y Monthly) | -0.72 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Fusion (FUSN) is expected to provide updates regarding the developmental program of its lead candidate, FPI-2265, for prostate cancer in the first-quarter earnings release.
Fusion Pharmaceuticals Inc. (FUSN) concluded the recent trading session at $21.42, signifying a +0.63% move from its prior day's close.
Fusion Pharmaceuticals Inc. (FUSN) concluded the recent trading session at $21.24, signifying a -0.09% move from its prior day's close.